2,N,N-TMT
From Infogalactic: the planetary knowledge core
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
(2-(2-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine
|
|
| Identifiers | |
| CAS Number | 1080-95-1  |
| Chemical data | |
| Formula | C13H18N2 |
| Molecular mass | 202.30 g/mol |
| (verify) | |
2,N,N-Trimethyltryptamine, 2,N,N-TMT, or 2-Me-DMT is a tryptamine derivative that is a psychedelic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#34).[1] It is claimed to show psychoactive effects at a dosage of 50–100 mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT2A receptor target that mediates the hallucinogenic effects of these drugs.
See also
References
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This Hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Psychedelic tryptamines
- Hallucinogen stubs
